CNX
53
-3
ABBV
53
-7
RRC
69
-3
ES
21
-3
TSCO
50
-2
CI
66
-3
CTSH
49
3
EMC
36
-6
DOW
32
-2
IPG
48
3
CTAS
37
-2
TAP
60
-3
PPG
41
-3
ROP
62
2
UHS
67
3
BA
47
2
NDAQ
66
2
NTAP
39
2
CL
48
-2
RL
66
-3
CNX
53
-3
ABBV
53
-7
RRC
69
-3
ES
21
-3
TSCO
50
-2
CI
66
-3
CTSH
49
3
EMC
36
-6
DOW
32
-2
IPG
48
3
CTAS
37
-2
TAP
60
-3
PPG
41
-3
ROP
62
2
UHS
67
3
BA
47
2
NDAQ
66
2
NTAP
39
2
CL
48
-2
RL
66
-3
Financhill
Back

Partners Group Holding AG Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
54

PGPHF
Partners Group Holding AG

Last Price:
$1,552.85
Seasonality Move:
12.28%
Buy
53

ALNY
Alnylam Pharmaceuticals

Last Price:
$269.17
Seasonality Move:
3.3%
Buy
54
Partners Group Holding AG (PGPHF) is a Buy

Is Partners Group Holding AG a Buy, Sell or Hold?

  • The current Partners Group Holding AG [PGPHF] share price is $1,509.31. The Score for PGPHF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • PGPHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Alnylam Pharmaceuticals (ALNY) is a Buy

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $280.96. The Score for ALNY is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PGPHF Stock Price Chart

What is Partners Group Holding AG's stock price today?

  • The Partners Group Holding AG share price today is $1,509.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PGPHF is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $280.96
    The current trend is moderately bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

PGPHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 52.31 Buy
Chaikin Money Flow: -39 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1466.07 - 1545.45) Buy
Bollinger Bands (100): (1392.17 - 1522.65) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.18 Buy
Relative Strength Index (14 RSI): 64.02 Buy
Chaikin Money Flow: -956276 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (237.98 - 264.74) Buy
Bollinger Bands (100): (240.44 - 271.42) Buy

PGPHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1492.9 Buy
20-day SMA: 1489.22 Buy
50-day SMA: 1502.37 Buy
200-day SMA: 1418.63 Buy
8-day EMA: 1494.28 Buy
20-day EMA: 1495.76 Buy
50-day EMA: 1489.88 Buy
200-day EMA: 1426.68 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 262.64 Buy
20-day SMA: 251.27 Buy
50-day SMA: 258.44 Buy
200-day SMA: 252.16 Buy
8-day EMA: 267.69 Buy
20-day EMA: 258.45 Buy
50-day EMA: 256.39 Buy
200-day EMA: 243.81 Buy

Partners Group Holding AG Earnings Growth & PGPHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Partners Group Holding AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):